Status:
COMPLETED
Propylene Glycol/Glycerol Intake and Cardiorespiratory Function
Lead Sponsor:
Université Libre de Bruxelles
Conditions:
Lung Injury
Eligibility:
MALE
18-60 years
Phase:
NA
Brief Summary
Propylene glycol/Glycerol intake is increasingly popular. The propylene glycol/glycerol intake effects on cardiorespiratory function are unknown.
Detailed Description
Background. Propylene glycol/Glycerol intake is increasingly popular. The propylene glycol/glycerol intake effects on cardiorespiratory function are unknown. Weaning of propylene glycol/glycerol could...
Eligibility Criteria
Inclusion
- Subject must be regular propylene glycol/glycerol/nicotine intake users since at least 1 year
- Subject must be former smokers
Exclusion
- Chronic or acute illness
- Substance abuse
- Chronic medication intake
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03410511
Start Date
January 15 2018
End Date
June 30 2020
Last Update
November 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme Hospital
Brussels, Anderlecht, Belgium, 1070